Biomedical Engineering Reference
In-Depth Information
institutional theory: (1) system confl ict due to coexistence of competing logics, (2)
institutional failure in resolving confl ict of logics that are amplifi ed by pharmaceuti-
cal marketing practices, and (3) continued escalation of confl icted logics that invite
regulatory intervention that constrains and restricts marketing efforts.
References
Camacho N, De Jong MG, Stremersch S (2012) The effect of customer empowerment on adher-
ence to expert advice. Working Paper, Erasmus University Rotterdam, The Netherlands.
Ding M, Eliashberg J (2002) Structuring the New Product Development Pipeline. Manage Sci
48(3):343-363.
Ding M, Eliashberg J (2008) A Dynamic Competitive Forecasting Model Incorporating Dyadic
Decision Making. Manage Sci 54(4):820-834.
Jack A (2011) Medicine approvals slump to lowest in decade.
Financial Times
.
http://www.ft.com/
June 2011
Pharmaceutical Research and Manufacturers of America (2010) PhRMA annual membership
survey. PhRMA, Washington, DC
Stremersch S, Lemmens A (2009) Sales growth of new pharmaceuticals across the globe: the role
of regulatory regimes. Market Sci 28 (4):690-708.
Stremersch S, Van Dyck W (2009) Marketing of the life sciences: a new framework and research
agenda for a nascent fi eld. J Market 73(4):4-30
United States Food and Drug Administration (FDA) (2008) FDA releases recommendations
regarding use of over-the-counter cough and cold products: products should not be used in
children under 2 years of age; Evaluation continues in older populations.
http://www.fda.gov/
NewsEvents/Newsroom/PressAnnouncements/2008/ucm116.htm]
.
Accessed 28 June 2011
Verniers I, Stremersch S, Croux C (2011) The global entry of new pharmaceuticals: a joint inves-
tigation of launch window and price. Int J Res Market 28 (4):295-308
Search WWH ::
Custom Search